University of Nicosia

Overview

The Drug Regulatory Affairs (Distance Learning) programme at the University of Nicosia equips students with the essential knowledge and skills required for roles in the regulation of medicines, biological and biotechnological products, and related healthcare items. The curriculum covers the entire drug development process, from regulatory planning and submissions to approval and post-marketing surveillance, ensuring a comprehensive understanding of the field.

What you'll study

Coursework focuses on the regulatory lifecycle, encompassing critical areas such as development planning, ethical considerations, submissions, quality and compliance, and post-approval monitoring.

• Drug Development and Ethical Considerations in the Pharma Industry
• The EU Regulatory Affairs System
• Regulatory Strategy and Marketing Applications for New Medicinal Products
• Quality Assurance and Compliance
• Clinical Trials, Preclinical and Clinical Development and Documentation

Learning approach: This distance learning programme features structured modules that delve into regulatory concepts, documentation practices, and compliance requirements relevant to the pharmaceutical and healthcare sectors.

Curriculum note: For detailed curriculum information, including module sequencing and available electives, prospective students should refer to the programme website.

Entry requirements

There are no specific GRE, GMAT, or GPA grading score requirements for this programme. However, candidates must demonstrate proficiency in English.

English requirements

To meet the English language requirements, applicants must have a minimum score of:

• IELTS 6.5 (or equivalent)
• TOEFL iBT 79 (or equivalent)

Career prospects

Graduates of the Drug Regulatory Affairs programme will be well-prepared for a variety of roles within the pharmaceutical industry, including positions in regulatory compliance, quality assurance, and drug development. The skills acquired in this programme will enable professionals to navigate the complex landscape of drug regulation and contribute to the successful introduction of new healthcare products to the market.